BioCentury | Jun 6, 2011
Company News

Mivac, Synthon deal

...with Mivac Development to research and develop multiple sclerosis (MS) candidates. The partners will use Mivac's...
...will develop and commercialize. Mivac is eligible for milestones and royalties. Details were not disclosed. Mivac Development AB...
BioCentury | Jun 1, 2011
Company News

Synthon, MIVAC in MS deal

...MIVAC Development AB (Goteborg, Sweden) to research and develop multiple sclerosis (MS) candidates. The partners will use MIVAC's...
Items per page:
1 - 2 of 2
BioCentury | Jun 6, 2011
Company News

Mivac, Synthon deal

...with Mivac Development to research and develop multiple sclerosis (MS) candidates. The partners will use Mivac's...
...will develop and commercialize. Mivac is eligible for milestones and royalties. Details were not disclosed. Mivac Development AB...
BioCentury | Jun 1, 2011
Company News

Synthon, MIVAC in MS deal

...MIVAC Development AB (Goteborg, Sweden) to research and develop multiple sclerosis (MS) candidates. The partners will use MIVAC's...
Items per page:
1 - 2 of 2